70 related articles for article (PubMed ID: 25265435)
1. Differential expression of miR-155 and miR-21 in tumor and stroma cells in diffuse large B-cell lymphoma.
Munch-Petersen HD; Ralfkiaer U; Sjö LD; Hother C; Asmar F; Nielsen BS; Brown P; Ralfkiaer E; Grønbæk K
Appl Immunohistochem Mol Morphol; 2015 Mar; 23(3):188-95. PubMed ID: 25265435
[TBL] [Abstract][Full Text] [Related]
2. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
Yao XX; Wang JF; Wang YH; Gao N
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
[TBL] [Abstract][Full Text] [Related]
3. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
Cao QW; Li HY; Yao XX; Wang JF
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
[TBL] [Abstract][Full Text] [Related]
4. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma.
Shepshelovich D; Ram R; Uziel O; Kushnir M; Lithwick-Yanai G; Hoshen M; Feinmesser M; Bairey O; Lahav M
Leuk Res; 2015 Jun; 39(6):632-7. PubMed ID: 25866097
[TBL] [Abstract][Full Text] [Related]
6. CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia.
Slack GW; Steidl C; Sehn LH; Gascoyne RD
Br J Haematol; 2014 Dec; 167(5):608-17. PubMed ID: 25135752
[TBL] [Abstract][Full Text] [Related]
7. A spindle cell variant of diffuse large B-cell lymphoma is characterized by T-cell/myofibrohistio-rich stromal alterations: analysis of 10 cases and a review of the literature.
Kimura Y; Arakawa F; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa A; Nakashima S; Ishibashi Y; Niino D; Sugita Y; Ishiyama K; Higuchi M; Takasaki Y; Shimomura T; Koike C; Kuwahara N; Fujikawa K; Ohshima K
Eur J Haematol; 2012 Oct; 89(4):302-10. PubMed ID: 22738254
[TBL] [Abstract][Full Text] [Related]
8. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling of low-grade and transformed nodal marginal zone lymphoma reveals a similar signature pattern distinct from diffuse large B cell lymphoma.
Gebauer N; Thorns C; Bernard V; Senft A; Schillert A; Merz H; Feller AC; Bernd HW
Acta Haematol; 2015; 133(2):214-20. PubMed ID: 25376122
[TBL] [Abstract][Full Text] [Related]
10. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarray in a subset of South African patients with DLBCL.
Sissolak G; Wood L; Smith L; Chan JW; Armitage J; Jacobs P
Transfus Apher Sci; 2013 Oct; 49(2):120-32. PubMed ID: 23942329
[TBL] [Abstract][Full Text] [Related]
12. DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells.
Jabłońska E; Białopiotrowicz E; Szydłowski M; Prochorec-Sobieszek M; Juszczyński P; Szumera-Ciećkiewicz A
Exp Hematol; 2020 Aug; 88():56-67.e2. PubMed ID: 32702393
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma.
Bedewy AML; Elmaghraby SM; Shehata AA; Kandil NS
Turk J Haematol; 2017 Aug; 34(3):207-212. PubMed ID: 28148469
[TBL] [Abstract][Full Text] [Related]
14. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
[TBL] [Abstract][Full Text] [Related]
15. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
16. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Thieblemont C; Briere J; Mounier N; Voelker HU; Cuccuini W; Hirchaud E; Rosenwald A; Jack A; Sundstrom C; Cogliatti S; Trougouboff P; Boudova L; Ysebaert L; Soulier J; Chevalier C; Bron D; Schmitz N; Gaulard P; Houlgatte R; Gisselbrecht C
J Clin Oncol; 2011 Nov; 29(31):4079-87. PubMed ID: 21947824
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of miR-21 in diffuse large B cell lymphoma].
Li CH; Fu R; Wang YH; Song WJ; Ruan EB; Qu W; Wang HQ; Wang GJ; Song J; Wang XM; Wu YH; Xing LM; Liu H; Li LJ; Guan J; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):339-43. PubMed ID: 24763002
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.
Hother C; Rasmussen PK; Joshi T; Reker D; Ralfkiær U; Workman CT; Heegaard S; Ralfkiær E; Grønbæk K
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5169-75. PubMed ID: 23821202
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma.
Gu L; Song G; Chen L; Nie Z; He B; Pan Y; Xu Y; Li R; Gao T; Cho WC; Wang S
Acta Haematol; 2013; 130(2):87-94. PubMed ID: 23548551
[TBL] [Abstract][Full Text] [Related]
20. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
